Cambridge Healthtech Institute’s 9th Annual

Infectious Disease Diagnostics

Emerging Technologies in the Post-Pandemic Era

March 27-28, 2024

The COVID-19 pandemic has fueled explosive innovation and investment in advanced technologies for infectious disease diagnostics. Cambridge Healthtech Institute’s 9th Annual Infectious Disease Diagnostics meeting will span applications in the clinic, community surveillance, pharmacy, resource-limited settings, and at-home diagnostics. Technology innovations include rapid infectious disease diagnostics and community surveillance, multiplexed testing and variant detection, antimicrobial resistance, NGS and metagenomics, host response, and more. Finally, regulatory, reimbursement, and market access strategies for advanced diagnostics in the post-pandemic era will be discussed.

Coverage will include, but is not limited to:

Rapid infectious disease diagnostics and community surveillance
Multiplex respiratory virus testing
Host response vs. pathogen detection
Antimicrobial susceptibility testing
Metagenomics-based diagnostics
Molecular diagnostics in resource-limited settings
Early detection of sepsis using artificial intelligence
Designing viral diagnostics with machine learning
New technologies for fungal infection diagnostics
Syndromic testing
Microbiome-based diagnostics

The deadline for priority consideration is September 1, 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: